Anchor Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Anchor Investment Management's PPH Position: Q1 2026 in Review
Anchor Investment Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 58 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #879.
Anchor Investment Management first reported a position in PPH in Q4 2017 and has held it in 34 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Anchor Investment Management held 58 shares of VanEck Pharmaceutical ETF worth $6.03K as of Q1 2026.
- Anchor Investment Management left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #879 holding.
- Anchor Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2017 and has held it in 34 quarters since.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.